NO156516C - Fremgangsmaate for fremstilling av modulatorer for immunsystemet. - Google Patents

Fremgangsmaate for fremstilling av modulatorer for immunsystemet.

Info

Publication number
NO156516C
NO156516C NO811626A NO811626A NO156516C NO 156516 C NO156516 C NO 156516C NO 811626 A NO811626 A NO 811626A NO 811626 A NO811626 A NO 811626A NO 156516 C NO156516 C NO 156516C
Authority
NO
Norway
Prior art keywords
modulators
effects
suppressor
human
immunity system
Prior art date
Application number
NO811626A
Other languages
English (en)
Norwegian (no)
Other versions
NO811626L (no
NO156516B (no
Inventor
A Arthur Gottlieb
Original Assignee
A Arthur Gottlieb
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by A Arthur Gottlieb filed Critical A Arthur Gottlieb
Publication of NO811626L publication Critical patent/NO811626L/no
Publication of NO156516B publication Critical patent/NO156516B/no
Publication of NO156516C publication Critical patent/NO156516C/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/05Immunological preparations stimulating the reticulo-endothelial system, e.g. against cancer
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14Blood; Artificial blood
    • A61K35/15Cells of the myeloid line, e.g. granulocytes, basophils, eosinophils, neutrophils, leucocytes, monocytes, macrophages or mast cells; Myeloid precursor cells; Antigen-presenting cells, e.g. dendritic cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32Bonded phase chromatography
    • B01D15/325Reversed phase
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/34Size-selective separation, e.g. size-exclusion chromatography; Gel filtration; Permeation
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/26Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 and B01D15/30 - B01D15/36, e.g. affinity, ligand exchange or chiral chromatography
    • B01D15/3847Multimodal interactions
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D15/00Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08Selective adsorption, e.g. chromatography
    • B01D15/42Selective adsorption, e.g. chromatography characterised by the development mode, e.g. by displacement or by elution
    • B01D15/424Elution mode
    • B01D15/426Specific type of solvent

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Developing For Electrophotography (AREA)
  • Dry Development In Electrophotography (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO811626A 1980-05-14 1981-05-13 Fremgangsmaate for fremstilling av modulatorer for immunsystemet. NO156516C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14973780A 1980-05-14 1980-05-14
US25688681A 1981-05-06 1981-05-06

Publications (3)

Publication Number Publication Date
NO811626L NO811626L (no) 1981-11-16
NO156516B NO156516B (no) 1987-06-29
NO156516C true NO156516C (no) 1987-10-07

Family

ID=26846987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO811626A NO156516C (no) 1980-05-14 1981-05-13 Fremgangsmaate for fremstilling av modulatorer for immunsystemet.

Country Status (11)

Country Link
EP (1) EP0042064B1 (fr)
JP (1) JPH0453848B2 (fr)
AU (1) AU555652B2 (fr)
CA (1) CA1163194A (fr)
DE (1) DE3176443D1 (fr)
DK (1) DK214481A (fr)
FI (1) FI78483C (fr)
IE (1) IE53572B1 (fr)
IL (1) IL62870A (fr)
NO (1) NO156516C (fr)
WO (1) WO1981003279A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4468379A (en) * 1982-05-06 1984-08-28 Endeavor Corp. Leukocyte extracts for affecting the immune system
US4616079A (en) * 1984-08-24 1986-10-07 Imreg, Inc. Immunoamplifiers and processes for the extraction thereof
CA1286989C (fr) * 1985-12-26 1991-07-30 A. Arthur Gottlieb Immunoamplificateurs et composes apparentes
EP0247538A3 (fr) * 1986-05-28 1989-08-30 Imreg, Inc. Immunosuppresseur et son procédé d'extraction
GB8614733D0 (en) * 1986-06-17 1986-07-23 Lefesvre A Aids treatment
ES2106784T3 (es) * 1990-07-02 1997-11-16 Nat Jewish Ct Immun & Respirat Factor de transferencia y metodos de uso.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3991182A (en) * 1971-10-19 1976-11-09 The Regents Of The University Of California Transfer factor
US4132776A (en) * 1978-02-15 1979-01-02 University Patents, Inc. Delivery of immunologically active components of transfer factor
US4180627A (en) * 1978-08-17 1979-12-25 The United States Of America As Represented By The Secretary Of Agriculture Process for in vivo transfer of cell-mediated immunity in mammals with alcoholic precipitates of Bovine Transfer factor
NO793412L (no) * 1978-10-25 1980-05-06 Benzon As Alfred Fremgangsmaate for fremstilling av overfoeringsfaktor mot patogene antigener

Also Published As

Publication number Publication date
IE811075L (en) 1981-11-14
JPS57500611A (fr) 1982-04-08
AU7057881A (en) 1981-11-19
EP0042064A3 (en) 1983-01-19
FI811473L (fi) 1981-11-15
IL62870A (en) 1985-03-31
NO811626L (no) 1981-11-16
AU555652B2 (en) 1986-10-02
CA1163194A (fr) 1984-03-06
DE3176443D1 (en) 1987-10-22
WO1981003279A1 (fr) 1981-11-26
NO156516B (no) 1987-06-29
FI78483B (fi) 1989-04-28
EP0042064B1 (fr) 1987-09-16
JPH0453848B2 (fr) 1992-08-27
DK214481A (da) 1981-11-15
IE53572B1 (en) 1988-12-21
EP0042064A2 (fr) 1981-12-23
FI78483C (fi) 1989-08-10
IL62870A0 (en) 1981-07-31

Similar Documents

Publication Publication Date Title
DE3375759D1 (en) Process for purifying modulators of the immune system
NO156553C (no) Fremgangsmaate for fremstilling av en vandig farmasoeytisk opploesning inneholdende ubidecarenon.
GB2079179B (en) Cosmetic composition based on an aqueous dispersion of small lipid spheres
NO883964L (no) Fremgangsmaate for fremstilling av et antioksydant-ekstrakt fra krydder.
NO821198L (no) Fremgangsmaate for fremstilling av preparater for behandling av melanomer.
NL192914B (nl) Werkwijze voor de bereiding van een antioxidant preparaat en daarmee verkregen preparaat.
IT8322141A0 (it) Procedimento di occultazione delle radiazioni visibile e infrarossa e munizione fumogena di attuazione di tale procedimento.
Ravizza et al. Hearing in primitive mammals: I. Opossum (Didelphis virginianus).
ATE179333T1 (de) Immunotherapeutische zubereitung
NL190399B (nl) Ijzer-bevattend eiwitmateriaal, bereiding daarvan, en farmaceutisch preparaat voor de behandeling van sideropene anaemie.
NO156516C (no) Fremgangsmaate for fremstilling av modulatorer for immunsystemet.
NO870476D0 (no) Fremgangsmaate for fremstilling av kryss-beskyttende humane monoklonale antistoffpreparater.
NL7610602A (nl) Werkwijze voor de bereiding van rodenticidepre- paraten en werkwijze voor de bereiding van de werkzame bestanddelen daarvan.
NL7612200A (nl) Retinezuurderivaat alsmede farmaceutisch preparaat voor de behandeling van acne.
NL182445B (nl) Zure, waterige, eetbare dispersie en werkwijze voor de bereiding daarvan.
EG16136A (en) Method of preparation for pesticidal pour-on formulations
NL7807890A (nl) Pyranochromoonderivaten, alsmede preparaten voor de be- handeling van allergische aandoeningen, die deze ver- bindingen bevatten.
NL7901941A (nl) Tegengif voor behandeling van dieren en pluimvee tegen acute vergiftiging door fosfororganische bestrijdings- middelen.
BE879987A (nl) Fenoxyfenoxypropionzuurderivaten, werkwijze ter bereiding daarvan, herbicidepreparaten die deze direvaten bevatten en methode ter bestrijding van onkruid onder toepassing van genoemde derivaten
NO140988C (no) Fremgangsmaate for fremstilling av agglomerater av silisium- eller silisiumlegeringspartikler
NL7902450A (nl) Farmaceutisch preparaat met anti-complementaire wer- king, werkwijze voor de bereiding daarvan alsmede werk- wijze voor het behandelen van nephritis.
IE832277L (en) 6-anilino-5, 8-quinoxalinediones.
IT8121484A0 (it) Estratto da piante del genere epimedium, procedimento per lapreparazione di detto estratto, agente immunostimolante che comprende detto estratto come componente efficace e immunoterapia mediante l'impiego di detto estratto.
NL7812403A (nl) Farmaceutisch preparaat voor de behandeling van diarree bij de mens.
NL188833C (nl) Preparaat op basis van water bevattende dispersies van bolvormige deeltjes.